| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0004563215618981 |
| P698 | PubMed publication ID | 26554904 |
| P50 | author | Robert J Shorten | Q121335310 |
| P2093 | author name string | Indran Balakrishnan | |
| P2860 | cites work | The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human | Q44447139 |
| Clinical ototoxicity of teicoplanin. | Q44867771 | ||
| The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial | Q44924916 | ||
| Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders | Q46064514 | ||
| Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes | Q46826187 | ||
| Therapeutic drug monitoring in the treatment of tuberculosis patients. | Q50984506 | ||
| Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P | Q24535844 | ||
| Nephrotoxicity of vancomycin, alone and with an aminoglycoside | Q28335291 | ||
| Pharmacological Studies with 5-Fluorocytosine | Q28363793 | ||
| Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA | Q30427912 | ||
| Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis | Q33449819 | ||
| In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model | Q33979115 | ||
| Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study | Q33982863 | ||
| Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients | Q34680655 | ||
| Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis | Q35007030 | ||
| Therapeutic drug monitoring in the treatment of active tuberculosis | Q35487794 | ||
| Effect of method of administration on extravascular penetration of four antibiotics | Q35676005 | ||
| Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults | Q35685548 | ||
| Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis | Q36042366 | ||
| The pharmacokinetic and pharmacodynamic properties of vancomycin | Q36328971 | ||
| Autoradiographic Localization of [ 3 H]Gentamicin in the Proximal Renal Tubules of Mice | Q36477519 | ||
| Vancomycin ototoxicity: a reevaluation in an era of increasing doses | Q37072057 | ||
| Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology | Q37688257 | ||
| Antibacterial activities and modes of action of vancomycin and related glycopeptides | Q37778683 | ||
| Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy | Q37956597 | ||
| Therapeutic drug monitoring in the treatment of tuberculosis: an update | Q38213320 | ||
| Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses | Q38269547 | ||
| Aminoglycoside-induced hearing loss in humans | Q38676819 | ||
| Single-base mutations at position 2661 of Escherichia coli 23S rRNA increase efficiency of translational proofreading | Q39940128 | ||
| Disposition of posaconazole following single-dose oral administration in healthy subjects | Q39955617 | ||
| Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli | Q40086724 | ||
| Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards | Q40285846 | ||
| The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of the | Q41092604 | ||
| Once-daily dosing of aminoglycosides: review and recommendations for clinical practice | Q41530531 | ||
| The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent | Q42022417 | ||
| Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin | Q42095864 | ||
| Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study. | Q42201109 | ||
| Teicoplanin: renal tolerance and pharmacokinetics in rats | Q42204153 | ||
| Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients | Q43427257 | ||
| P433 | issue | Pt 3 | |
| P304 | page(s) | 333-346 | |
| P577 | publication date | 2015-11-10 | |
| P1433 | published in | Annals of Clinical Biochemistry | Q15716536 |
| P1476 | title | Therapeutic drug monitoring of antimicrobials | |
| P478 | volume | 53 |
| Q59318102 | A method employing SPE, MRM LC-MS/MS and a THF–water solvent system for the simultaneous determination of five antiretroviral drugs in human blood plasma |
| Q40414215 | Development of a liquid chromatography tandem mass spectrometry method for the simultaneous measurement of voriconazole, posaconazole and itraconazole |
Search more.